Dinesh V. Ph D. Patel, President and CEO at Protagonist Therapeutics, Inc (PTGX), sold 104,888 shares at $54.86 ($5.8M) on 2025-07-21, disclosed to the SEC on 2025-07-23.
Open-market sale of $5.8M PTGX by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $54.86 | 12,859 | $705K | 12.2% |
| 2 | $54.86 | 12,859 | $705K | 12.2% |
| 3 | $55.05 | 22,065 | $1.2M | 21.1% |
| 4 | $55.05 | 22,065 | $1.2M | 21.1% |
| 5 | $54.79 | 17,520 | $960K | 16.7% |
| 6 | $54.79 | 17,520 |
| $960K |
| 16.7% |
| Total | $54.92 avg | 104,888 | $5.8M | 100% |
| Filing → |
| PTGX | SELL | 2026-03-25 | $5.5M | — | Filing → |
| PTGX | SELL | 2026-01-27 | $4.1M | — | Filing → |
| PTGX | SELL | 2026-01-21 | $2.8M | — | Filing → |